Oral drugs in the HR-positive, HER2-negative metastatic breast cancer space put a focus on clear patient-provider ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Panelists discuss how the current treatment landscape for chronic graft-versus-host disease includes a range of immunosuppressive approaches, from traditional corticosteroids and calcineurin ...

“We [as oncology nurses] end up establishing good rapports with our patients, and we’re basically the frontlines to nutritional deficiencies,” DiRubbo said. “So assessing nutritional needs from the ...

Panelists discuss how physician assistants educate and empower chronic graft-versus-host disease patients and their caregivers to recognize, report, and manage symptoms effectively, detailing ...

Oncology nurses and APPs play a role in supporting caregivers while the patient they care for receives a diagnosis and cancer ...

Oncology nurses should inform patients about adverse events and the signs of interstitial lung disease before treating their breast cancer with T-DXd.